Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance). - Battaglin F; O'Neil BH; Stintzing S; Ou FS; Zemla TJ; Niedzwiecki D; Innocenti F; Hochster HS; von Weikersthal LF; Decker T; Kiani A; Vehling-Kaiser U; et al. (European journal of cancer (Oxford, England : 1990), 2025)